Publication
Generative AI
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Around the globe, pharmaceutical and medical device companies are helping in the fight of the COVID-19 pandemic. Many of these companies may have patents pertaining to technology that could be used for the benefit of the broader public during this time of crisis, such as patents on ventilators, diagnostic tests, pharmaceuticals or personal protective equipment. Governments around the globe have mechanisms in place that can mandate the use of patented inventions during a national emergency.
The reference guide provides a high-level overview of the governmental authorization provisions in Canada, the United States, France, Germany, the Netherlands, the United Kingdom, Hong Kong, China, Singapore and Australia.
Publication
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Publication
The Copyright Act provides that a copyright owner must bring an infringement claim within three years of its accrual.
Publication
The Department of the Treasury OFAC announced sanctions on one dozen entities, individuals and vessels involved in financing and facilitating the clandestine sale of Iranian UAVs for Iran’s Ministry of Defense and Armed Forces Logistics.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023